Molecular Devices

Molecular Devices offers high-performance bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development. Its products are designed to help scientists increase productivity and efficiency in scientific discovery and research.

Molecular Devices serves a broad range of research areas, including automated high-throughput screening solutions, microplate readers and software that help scientists advance protein and cell biology. One of the company's main areas of focus is 3D biology, where proprietary bioprocess technology is used to generate reliable and predictive organoids at scale, enabling more effective drug discovery and personalized medicine.

Some of the key features and tools include:

• CellXpress.ai: An AI-driven cell culture system that automates processes, monitors, feeds, images and schedules assays for better reliability and reproducibility.
• 3D Ready Organoid Expansion Service: Manufactures quality-controlled organoids at scale for high-throughput screening.
• Organoid Innovation Center: A collaborative space with automated workflows for organoid culturing and screening.
• ImageXpress High-Content Confocal Imaging System: Offers automated digital microscopy and high-throughput confocal imaging with AI-driven software analysis.
• Clone Screening Systems: Includes colony picker platforms for synthetic biology, antibody discovery and cell line development.
• BioAssemblyBot 400 Bioprinter: Automates 3D bioprinting for high-content screening and organoid development.

Molecular Devices is committed to empowering scientists to advance discovery by providing end-to-end solutions that span across research disciplines. The company's products have been cited in the life science research industry thousands of times, and its GxP compliance solutions help laboratories meet regulatory requirements.

By offering these advanced tools and services, Molecular Devices enables researchers to move to more complex, physiologically-relevant 3D cell models, accelerating the development of life-saving therapeutics and improving the quality of human life around the world.

Published on July 18, 2024